560 related articles for article (PubMed ID: 27449594)
21. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
22. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.
Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV
ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antimicrobial activity of 3,4-bis(arylthio)maleimides.
Panov AA; Lavrenov SN; Simonov AY; Mirchink EP; Isakova EB; Trenin AS
J Antibiot (Tokyo); 2019 Feb; 72(2):122-124. PubMed ID: 30482908
[TBL] [Abstract][Full Text] [Related]
24. The hydrophobic trap-the Achilles heel of RND efflux pumps.
Aron Z; Opperman TJ
Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
[TBL] [Abstract][Full Text] [Related]
25. A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
Yang X; Goswami S; Gorityala BK; Domalaon R; Lyu Y; Kumar A; Zhanel GG; Schweizer F
J Med Chem; 2017 May; 60(9):3913-3932. PubMed ID: 28399372
[TBL] [Abstract][Full Text] [Related]
26. RND efflux pumps: structural information translated into function and inhibition mechanisms.
Ruggerone P; Murakami S; Pos KM; Vargiu AV
Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360
[TBL] [Abstract][Full Text] [Related]
27. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates.
Malléa M; Mahamoud A; Chevalier J; Alibert-Franco S; Brouant P; Barbe J; Pagès JM
Biochem J; 2003 Dec; 376(Pt 3):801-5. PubMed ID: 12959639
[TBL] [Abstract][Full Text] [Related]
28. [MDR efflux pumps and antimicrobial resistance].
Sánchez Díaz P
Rev Esp Quimioter; 2003 Jun; 16(2):172-87. PubMed ID: 12973455
[TBL] [Abstract][Full Text] [Related]
29. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of efflux pump-based antibiotic resistance.
Zgurskaya HI
Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance.
Thakur V; Uniyal A; Tiwari V
Eur J Pharmacol; 2021 Jul; 903():174151. PubMed ID: 33964293
[TBL] [Abstract][Full Text] [Related]
32. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
[TBL] [Abstract][Full Text] [Related]
33. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
[TBL] [Abstract][Full Text] [Related]
34. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
Schweizer HP
Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
[TBL] [Abstract][Full Text] [Related]
35. Characterization of putative multidrug resistance transporters of the major facilitator-superfamily expressed in Salmonella Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; De Zorzi R; Mirza O; Walz T; Rahman M
J Infect Chemother; 2015 May; 21(5):357-62. PubMed ID: 25724589
[TBL] [Abstract][Full Text] [Related]
36. Case study on the soil antibiotic resistome in an urban community garden.
Mafiz A; Perera LN; He Y; Zhang W; Xiao S; Hao W; Sun S; Zhou K; Zhang Y
Int J Antimicrob Agents; 2018 Aug; 52(2):241-250. PubMed ID: 29857032
[TBL] [Abstract][Full Text] [Related]
37. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
38. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.
Piddock LJ
Clin Microbiol Rev; 2006 Apr; 19(2):382-402. PubMed ID: 16614254
[TBL] [Abstract][Full Text] [Related]
39. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
[TBL] [Abstract][Full Text] [Related]
40. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria.
Lubelski J; Konings WN; Driessen AJ
Microbiol Mol Biol Rev; 2007 Sep; 71(3):463-76. PubMed ID: 17804667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
